One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

An Austrian biotech firm that moved into Cambridge in 2008 has raised £7.2m (EUR 8m)

Published on 6 January, 2010

“f-star, which has developed novel antibody engineering technology, moved to the Babraham Research campus in March 2008 in order to build closer links with the Medical Research Council’s Laboratory of Molecular Biology (LMB) in Cambridge – an acknowledged world leader in antibody science.” More…